期刊文献+

复方自乳化半固体珍菊降压胶囊剂的制备及其性质考察 被引量:6

Self-microemulsifying semi-solid matrix hard capsules to treat hypertension:in vitro study
下载PDF
导出
摘要 目的制备复方自乳化半固体珍菊降压胶囊剂,以期提高其主要成分(芦丁和氢氯噻嗪)溶出度及生物利用度。方法通过溶解度实验和绘制伪三元相图的方法进行自乳化处方的筛选,以载药量、载油量及粒径等为指标应用单纯形网格法优化处方;采用熔融法制备半固体胶囊并对该半固体胶囊进行稳定性影响因素考察及药物溶出度测定。结果复方自乳化半固体珍菊降压胶囊剂最优处方为泊洛沙姆188-油酸乙酯-聚乙二醇辛基苯基醚-聚乙二醇400(质量比28.6∶8.4∶44.1∶19.1),该制剂中主要成分芦丁和氢氯噻嗪载药量为128.8、57.7 mg.g-1;60℃、光照下含量明显下降;复方自乳化半固体胶囊剂和市售胶囊剂1 h药物溶出度分别为100%、48.1%。结论所制备的复方自乳化半固体胶囊剂具有载药量高、溶出度好的特点。 Objective To develop the formulation of Zhenju Jiangya(traditional Chinese medicines)self-microemulsifying semi-solid matrix hard capsule drug delivery system and evaluate the dissolutions and bioavailabilities of hydrochlorothiazide and rutin.Methods The contents of hydrochlorothiazide and rutin were measured by HPLC.Pseudo-ternary phase diagrams were constructed identifying the efficient self-emulsification region.In vitro dissolution determination was carried out.Results The in vitro dissolution of self-microemulsifying semi-solid matrix hard capsules was about twofold higher than that of commercially available capsules.Conclusions The self-microemulsifying semi-solid matrix hard capsules can be successfully formulated with high drug loading rate and dissolution.It may be a promising alternative for the treatment of hypertension.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2011年第1期1-5,共5页 Journal of Shenyang Pharmaceutical University
关键词 自乳化 半固体骨架 芦丁 氢氯噻嗪 性质 self-microemulsifying semi-solid matrix rutin hydrochlorothiazide property
  • 相关文献

参考文献5

二级参考文献32

  • 1Baykara T, Yüksel N. The preparation of prolonged acion formulations in the form of semisolid matrix into hard gelatin capsules of oxprenolol Ⅱ. Thixocap method[J].Drug Dev Ind Pharm,1992,18(2):233-243. 被引量:1
  • 2Jose G R. Controlled release pharmaceutical composition[P]. US:6491950 B1, 2002-12-10. 被引量:1
  • 3Jose G R, Josephine D, Saul A, et al. Controlled release pharmaceutical composition[P]. US:6524615 B2,2003-02-25. 被引量:1
  • 4Walker S E, Bedford K, Eaves T. Improvements in and relating to pharmaceutical preparations in solid unit dosage form[P]. GB:1572226,1980-07-30. 被引量:1
  • 5Rowley G, Hawley A R, Dobson C L, et al. Rheology and filling characteristics of particulate dispersions in polymer melt formulations for liquid filled hard gelatin capsules[J]. Drug Dev Ind Pharm, 1998, 24(7):605-611. 被引量:1
  • 6Thakkar A L, Gibson L L, Grove B. Orally administerable sustained release pharmacerutical formulations[P]. US:4797286,1989-01-10. 被引量:1
  • 7Erlich L A, Yu D, Pallister D A, et al. Relative bioav-ailability of danazol in dogs from liquid-filled hard gelatin capsules[J]. Int J Pharm, 1999, 179:49-53. 被引量:1
  • 8Halbaut L, Barbè C, del Pozo A. An investigation into physical and chemical properties of semi-solid self-emulsifying systems for hard gelatin capsules[J]. Int J Pharm, 1996, 130: 203-212. 被引量:1
  • 9Heimendinger J. Drug release from semi-solid matrix systems in hard capsules[J]. Drug Dev Ind Pharm, 1989, 15(14-16): 2407-2417. 被引量:1
  • 10Roussin P, Duddu S. Sustained release theophylline for-mulations, excipient systems and methods of production[P]. US:6171615 B1, 2001-01-09. 被引量:1

共引文献42

同被引文献106

引证文献6

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部